<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/1995-1191-2010-4-33-38</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-342</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Трансплантомика</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Transplantomics</subject></subj-group></article-categories><title-group><article-title>НЕОДНОЗНАЧНОСТИ ЛОКУСОВ ПРИ ПРОВЕДЕНИИ HLA-ТИПИРОВАНИЯ ПО ТЕХНОЛОГИИ SSO И ПОПЫТКА ИХ РАЗРЕШЕНИЯ</article-title><trans-title-group xml:lang="en"><trans-title>AMBIGUITY OF LOCI DURING HLA-TYPING ON SSO TECHNOLOGY AND ATTEMPT TO RESOLVE THEM</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Логинова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Loginova</surname><given-names>M. A.</given-names></name></name-alternatives><email xlink:type="simple">Loginova-MA@rosplasma.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Парамонов</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Paramonov</surname><given-names>I. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Трофимова</surname><given-names>Н. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Trofimova</surname><given-names>N. P.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГУ «ПОМЦЭКПКИФДП Росздравнадзора», Киров</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Volga Federal District Medical Center of Expertise of Blood Products Quality and Investigation of Donor Plasma Fractionation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>09</day><month>06</month><year>2014</year></pub-date><volume>12</volume><issue>4</issue><issue-title>ВЕСТНИК ТРАНСПЛАНТОЛОГИИ И ИСКУССТВЕННЫХ ОРГАНОВ том XII No 4–2010</issue-title><fpage>33</fpage><lpage>38</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Логинова М.А., Парамонов И.В., Трофимова Н.П., 2010</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="ru">Логинова М.А., Парамонов И.В., Трофимова Н.П.</copyright-holder><copyright-holder xml:lang="en">Loginova M.A., Paramonov I.V., Trofimova N.P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/342">https://journal.transpl.ru/vtio/article/view/342</self-uri><abstract><p>Проведено HLA-типирование 705 потенциальных доноров гемопоэтических стволовых клеток, прожи- вающих на территории Приволжского федерального округа, по локусам (HLA)-A, B, DRB1 и 155 из их числа по локусу HLA-C. 48 образцов не могут быть внесены в базу данных по причине выявления ал- лельных неоднозначностей по HLA-локусам I класса – HLA-A, HLA-B. Для раскрытия неоднозначно- стей использовали наборы реагентов AlleleSEQR HLA Sequencing, которые позволили раскрыть неодно- значности по локусу HLA-A в 44% случаев, по локусам HLA-B и HLA-С – в 40% случаев. Применение программного обеспечения HARPs Finder показало возможность раскрытия всех выявленных аллельных неоднозначностей (исключение неоднозначности типов – A*03/A*32 или A*74:13/A*32:04 и A*01/A*11 или A*36:04/A*11) при дополнении базовых наборов AlleleSEQR HLA Sequencing наборами реагентов AlleleSEQR HARPs. </p></abstract><trans-abstract xml:lang="en"><p>Sequence specific oligonucleotides typing was used to identify human leukocyte antigen (HLA)-A, B, DRB1 alleles from 705 recruited volunteers with Volga Federal District for unrelated hematopoietic stem cell registry and 155 of their number at locus HLA-C. 48 samples cannot be entered into the database because of ambiguities in the identification of allelic loci on HLA-class I – HLA-A, HLA-B. To resolution of ambiguity use reagents kits AlleleSEQR HLA Sequencing, which allowed to reveal the ambiguity of the locus HLA-A, 44% of cases, the loci HLA-B and HLA-C – 40% of cases. Application software HARPs Finder showed the possibility of resolution of all identified allelic ambiguities (with the exception of types of ambiguity – A*03/A*32 or A*74:13/A*32:04 and A*01/A*11 or A*36:04/A*11) with the addition of basic kits AlleleSEQR HLA Sequencing reagents kit Al- leleSEQR HARPs. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>HLA-типирование.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>HLA-typing</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Блау И.В. Изучение HLA и подбор донора для неродственной трансплантации стволовых гемопоэтиче- ских клеток // Вестник гематологии. 2009. Т. V. No 4. С. 10–11.</mixed-citation><mixed-citation xml:lang="en">Блау И.В. Изучение HLA и подбор донора для неродственной трансплантации стволовых гемопоэтиче- ских клеток // Вестник гематологии. 2009. Т. V. No 4. С. 10–11.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Головкина Л.Л., Кутьина Р.М., Пушкина Т.Д. Опти- мальный метод тканевого типирования больных заболеваниями систем крови и доноров гемопоэтиче- ских стволовых клеток // Вестник гематологии. 2009. Т. V. No 4. С. 21–22.</mixed-citation><mixed-citation xml:lang="en">Головкина Л.Л., Кутьина Р.М., Пушкина Т.Д. Опти- мальный метод тканевого типирования больных заболеваниями систем крови и доноров гемопоэтиче- ских стволовых клеток // Вестник гематологии. 2009. Т. V. No 4. С. 21–22.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Еличева З.М., Усманова И.З., Куликова С.Н. Срав- нительный анализ серологического и молекулярно-генетического методов HLA-типирования // Вестник</mixed-citation><mixed-citation xml:lang="en">Еличева З.М., Усманова И.З., Куликова С.Н. Срав- нительный анализ серологического и молекулярно-генетического методов HLA-типирования // Вестник</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">гематологии. 2009. Т. V. No 4. С. 29–30.</mixed-citation><mixed-citation xml:lang="en">гематологии. 2009. Т. V. No 4. С. 29–30.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Иоффе Ю.Г. Современное состояние неродственно- го донорства гемопоэтических стволовых клеток в Российской Федерации // Клиническая онкогематология. 2009. Т. 2. No 3. С. 344–346.</mixed-citation><mixed-citation xml:lang="en">Иоффе Ю.Г. Современное состояние неродственно- го донорства гемопоэтических стволовых клеток в Российской Федерации // Клиническая онкогематология. 2009. Т. 2. No 3. С. 344–346.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Laboratory Manual American Society for Histocompatibility and Immunogenetics. – 4th edition.</mixed-citation><mixed-citation xml:lang="en">Laboratory Manual American Society for Histocompatibility and Immunogenetics. – 4th edition.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S.J., Klein J., Haagenson M. et al. High-resolution donor-recipient HLA matching contributes to the suc- cess of unrelated donor marrow transplantation // Blood. 2007. No 110. P. 4576–4583.</mixed-citation><mixed-citation xml:lang="en">Lee S.J., Klein J., Haagenson M. et al. High-resolution donor-recipient HLA matching contributes to the suc- cess of unrelated donor marrow transplantation // Blood. 2007. No 110. P. 4576–4583.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mackay I., Rosen F.S. The HLA system // The New England Journal of Medicine. 2000. Vol. 343. No 11. P. 782–</mixed-citation><mixed-citation xml:lang="en">Mackay I., Rosen F.S. The HLA system // The New England Journal of Medicine. 2000. Vol. 343. No 11. P. 782–</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Petersdorf E.W., Gooley T.A., Anasetti C. et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient // Blood. 1998. No 98. P. 3515– 3520.</mixed-citation><mixed-citation xml:lang="en">Petersdorf E.W., Gooley T.A., Anasetti C. et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient // Blood. 1998. No 98. P. 3515– 3520.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sasazuki T., Juji T., Morishima Y. et al. Effect of match- ing of class HLA alleles on clinical outcome after trans- plantation of hematopoietic stem cells from unrelated donor // The New England Journal of Medicine. 1998. Vol. 339. No 17. P. 1177–1186.</mixed-citation><mixed-citation xml:lang="en">Sasazuki T., Juji T., Morishima Y. et al. Effect of match- ing of class HLA alleles on clinical outcome after trans- plantation of hematopoietic stem cells from unrelated donor // The New England Journal of Medicine. 1998. Vol. 339. No 17. P. 1177–1186.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Standards for Accredited Laboratories American Soci- ety for Histocompatibility and Immunogenetics. 2009. http://www.ashi-hla.org/lab-center/accreditation/forms/ standards/.</mixed-citation><mixed-citation xml:lang="en">Standards for Accredited Laboratories American Soci- ety for Histocompatibility and Immunogenetics. 2009. http://www.ashi-hla.org/lab-center/accreditation/forms/ standards/.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Standarts for histocompatibility testing. European Fed- eration for Immunogenetics. 2008. Vol. 5.6.</mixed-citation><mixed-citation xml:lang="en">Standarts for histocompatibility testing. European Fed- eration for Immunogenetics. 2008. Vol. 5.6.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
